CPC A61K 51/0476 (2013.01) [A61K 31/164 (2013.01); A61K 33/30 (2013.01); A61P 35/00 (2018.01)] | 9 Claims |
1. A method of reducing melanoma tumor growth of a primary melanoma in a patient in need thereof, comprising suppressing tumor growth of the primary melanoma by administering a composition comprising a therapeutically effective amount of 64Zne(Asp)2 to said patient, wherein from 0.2 μg/kg to 2000 mg/kg patient weight/day of 64Zne(Asp)2 is administered to the patient and wherein the 64Zne(Asp)2 is at least 90% the L-enantiomer.
|